<i>NTRK</i> Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente Rodrigues Marczyk, Maria E. Cabanillas, Sarah Hamidi et al.|JCO Precision Oncology|2025Cited by 10
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid CancerMaria E. Cabanillas, Sarah Hamidi, Renata Ferrarotto et al.|Thyroid|2025Cited by 8
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy DeferralStephanie O. Dudzinski, Matthew S. Ning, Anita K. Ying et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 5
Characterization of Advanced <i>RAS</i> -driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic AvenuesSarah Hamidi, Maria E. Cabanillas, Marie‐Claude Hofmann et al.|The Journal of Clinical Endocrinology & Metabolism|2025Cited by 5
Erratum: NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente Rodrigues Marczyk, Maria E. Cabanillas, Sarah Hamidi et al.|JCO Precision Oncology|2025Cited by 4